# Publisher Report — glp-1-market hub refresh (draft-v4-publisher-final)

Final packaging/checklist pass over `draft-v2-editor.md` → `draft-v4-publisher-final.md`. No body content rewritten; frontmatter finalized for CMS handoff and claim markers retained per instruction (to be stripped at the point of CMS publish, not before).

Date: 2026-08-01. Byline: Assel Sekerova. Status: `draft` (ready for Vadim's final approval before CMS publish).

---

## 1. Word count

**~3,520 words** (body, excluding frontmatter) — carried forward from the editor's count in `phase2-editor-report.md` §1. Within the campaign-manager band of 3,150–3,650 and the plan's stated total (~3,000–3,600). No content was added or removed at this stage. **PASS.**

---

## 2. Section list (all 12 H2 titles, in order)

1. The GLP-1 Market Moment
2. Short Answer: What This Hub Covers
3. GLP-1 Market Growth: Size and Trajectory
4. The Progress-Tracking Gap
5. Why Progress Tracking Is Becoming Table Stakes
6. Body Composition Beyond the Scale
7. Program Models and Where Tracking Fits
8. Telehealth and Remote Check-ins
9. Clinic Workflow at Scale
10. Where FitXpress Fits
11. What FitXpress Does NOT Do
12. FAQs, Next Steps, and CTA

All 12 sections from the plan's fixed 12-part hub structure are present in order. **PASS.**

---

## 3. Internal links used, grouped by direction

**Up (2):**
- Main Health hub — https://3dlook.ai/content-hub/ai-body-data-health-hub/ (H2.10)
- AI in Fitness hub — https://3dlook.ai/content-hub/ai-in-fitness-industry/ (H2.10)

**Side (9):**
- Visual Progress Tracking for GLP-1 — https://3dlook.ai/content-hub/visual-progress-tracking-glp1-adherence-retention/ (H2.2, H2.5)
- Beyond BMI — https://3dlook.ai/content-hub/beyond-bmi-business/ (H2.2, H2.6)
- Online Pharmacy BMI Verification — https://3dlook.ai/content-hub/online-pharmacy-bmi-verification-a-2026-compliance-guide/ (H2.2, H2.7, H2.10)
- GLP-1 Compliance Challenge — https://3dlook.ai/content-hub/glp-1-compliance-challenge/ (H2.2)
- Weight Loss Industry Overview — https://3dlook.ai/content-hub/weight-loss-industry-overview/ (H2.7)
- Top 10 Weight Loss Clinic Marketing Tips — https://3dlook.ai/content-hub/top-10-weight-loss-clinic-marketing-tips/ (H2.7)
- Body Scanning Technology for Weight Loss — https://3dlook.ai/content-hub/body-scanning-technology-for-weight-loss/ (H2.8)
- Bariatric Pre-Qualification — https://3dlook.ai/content-hub/bariatric-pre-qualification-mobile-3d-body-scanning/ (H2.9)
- How 3DLOOK Turns Two Photos Into Structured Body Data — https://3dlook.ai/content-hub/3dlook-turns-two-photos-structured-body-data/ (H2.10)

**Down (1, referenced twice):**
- FitXpress for Telehealth and Weight Loss — https://3dlook.ai/fitxpress/for-telehealth-and-weight-loss/ (H2.10 mention; H2.12 Next Steps / BOFU CTA)

**Trust (2):**
- Mobile Body Scanning Accuracy framework — https://3dlook.ai/content-hub/mobile-body-scanning-accuracy/ (H2.10)
- Legal information — https://3dlook.ai/legal/ (H2.12 scope disclaimer)

All 4 required directions (up / side / down / trust) present. All 14 internal URLs confirmed live by the campaign manager (orchestrator) on 2026-08-01 per the task brief, including `/legal/` (live on retry) and both up-links previously flagged as unconfirmed in content-plan.csv. **PASS — no open action here.**

---

## 4. External sources used

- J.P. Morgan Research, "Obesity drugs" — https://www.jpmorgan.com/insights/global-research/current-events/obesity-drugs (H2.3, FAQ #2) — market size (~$200B by 2030), US patient-count trajectory, diabetes/obesity penetration rates
- KFF 2025 Employer Health Benefits Survey — https://www.kff.org/health-costs/2025-employer-health-benefits-survey/ (H2.3) — employer GLP-1 coverage (43% vs. 28%)
- STAT News, Hims & Hers FY2025 earnings coverage — https://www.statnews.com/2026/02/23/him-hers-earnings-2026-outlook-compounded-semaglutide/ (H2.3) — digital-health revenue/subscriber scaling

All 3 confirmed live and resolving on 2026-08-01 per the task brief. **PASS.**

---

## 5. Claims used (traced to proof-points.md, per editor's verification in phase2-editor-report.md §3)

- FX-001 — 96-97% accuracy vs. manual measurement (qualified, never bare/universal; separated from FX-003) — H2.10
- FX-003 — scan-to-scan repeatability < 1 cm — H2.9, H2.10
- FX-004 — weight estimation ±3.5% average error (software signal, not scale replacement) — H2.10
- FX-005 — under 45 seconds, 2 photos (front + side) — H2.8, H2.10, FAQ
- FX-006 — 80+ body measurements — H2.8, H2.10, FAQ
- FX-007 — BMI, BMR, body fat %, lean mass, fat mass — H2.6, H2.10, FAQ
- FX-009 — UK Meds, online-pharmacy BMI verification (cross-vertical, one line) — H2.10
- FX-010 — Yazen, 34,000 scans in 2025 — H2.10
- FX-012 — HIPAA / GDPR / no personal identifiers / photos deleted after processing / not a medical device — H2.2, H2.10, H2.11, FAQ

All 9 claims traced; no invented numbers; no drug clinical-efficacy figures asserted as FitXpress claims. **PASS.**

---

## 6. Final delivery checklist

- [x] Terminology / banned-word spot re-check: no hits for em dash rhetoric, "leverage," "utilize," "harness," "robust," "seamless," "comprehensive," "delve," "game-changer," "revolutionary," "cutting-edge," "unlock," triple parallelisms, or sentence-opening "Furthermore/Moreover/Additionally." (Confirmed clean by editor's full grep in phase2-editor-report.md §2; spot-checked again at this pass — no regressions, since body text is unchanged from draft-v2.)
- [x] Claim markers (`<!-- claim: FX-XXX -->`) present and traceable to proof-points.md for all 9 claims — **retained in this draft on purpose; must be stripped before CMS publish** (see action item below).
- [x] All 4 internal-link directions present: up (2), side (9), down (1, referenced twice), trust (2).
- [x] FAQ present with all 8 required questions, each answered in 2-5 sentences, GEO/AEO-friendly (direct answer first).
- [x] Frontmatter complete: slug, product, title, primary_keyword, secondary_keyword, meta_description, primary_use_case, hub, cluster, intent, action_type, priority, existing_urls, cannibalization_guardrail, vertical_boundary, author, status, created, claims_used.
- [x] Word count in range: ~3,520 words (target 3,000-3,600 / campaign-manager band 3,150-3,650).
- [x] Byline correct: Assel Sekerova (per plan.md's default-author instruction and the refresh decision already recorded in the editor pass; live-CMS confirmation still owed, see open issues).
- [x] "What FitXpress Does NOT Do" section present (H2.11) and mirrors the vertical_boundary field exactly.
- [x] Meta title = fixed H1 exactly ("GLP-1 Market Growth and the Need for Better Patient Progress Tracking"); meta_description ~152 chars, primary keyword not repeated verbatim from title.
- [x] Single BOFU CTA in H2.12 close, no repeated hard CTA per section, scope disclaimer follows the CTA.

**Action item for CMS publish (explicit, not optional):** strip all `<!-- claim: FX-XXX -->` HTML comments from the body before pushing to CMS. They are retained in `draft-v4-publisher-final.md` intentionally, for internal claims-audit traceability, and must not ship to the live page.

---

## 7. Open issues remaining for Vadim

Two legitimate open items carried forward from the editor's report (`phase2-editor-report.md` §10); no new issues introduced at this pass:

1. **Byline reassignment confirmation on live CMS.** The refresh reassigns the byline from Dana Vioreanu (current live page) to Assel Sekerova (default author per CLAUDE.md §15). Confirm this reassignment is acceptable on the live CMS record before publish, since the URL and page are being updated in place (`https://3dlook.ai/content-hub/glp-1-market/`).
2. **Periodic external-source freshness re-check.** The three external market-research citations (J.P. Morgan, KFF, STAT News) were live-verified on 2026-08-01. Because these are third-party market figures (not evergreen product facts), Vadim should schedule a periodic freshness check (e.g., alongside the next scheduled hub refresh) to confirm the figures and links still hold, per standard practice for externally-sourced market data.

No unresolved claims-discipline, boundary/cannibalization, or link-integrity issues remain. All internal/external URLs are live-confirmed per the task brief, so no further HTTP-verification action item is needed at this stage.
